Stryker Announces Appointment of Scott Bruder, MD, PhD to the Position of Vice President, Chief Medical and Scientific Officer
Kalamazoo, Michigan - (January 7, 2013) - Stryker Corporation (NYSE:SYK)
announced that Scott P. Bruder, MD, PhD has joined the Company in the newly
created position of Vice President, Chief Medical and Scientific Officer,
reporting to Kevin A. Lobo, President and Chief Executive Officer. In this
role, Dr. Bruder will oversee the clinical and scientific efforts of Stryker
Corporation, including academic, industrial and governmental scientific
partnerships. In addition, he will represent Stryker as the leading medical
authority of the Company for trade associations, regulatory bodies, and other
entities while also partnering with our teams across the organization.
Dr. Bruder has a long and distinguished track record of performance with more
than 20 issued and pending patents, nearly 150 publications and numerous honors
from the American Academy of Orthopaedic Surgeons, the Orthopaedic Research
Society and the Association of Bone and Joint Surgeons. For the past five
years, Dr. Bruder worked at Becton, Dickinson and Company as the Chief Science
and Technology Officer, where he was responsible for identifying and cultivating
new growth opportunities, improving the product development system and enhancing
global research capabilities. Prior to that, Dr. Bruder spent 8 years at
Johnson & Johnson in a series of senior executive and scientific roles in
various businesses. Earlier in his career, Dr. Bruder held leadership roles at
Anika Therapeutics and Osiris Therapeutics.
Dr. Bruder is a graduate from Brown University and Case Western Reserve
University (CWRU) School of Medicine, where he also earned a PhD in stem cell
biology, before obtaining additional surgical training at the University of
Pennsylvania. He maintains an active academic presence as an Adjunct Professor
of Biomedical Engineering at CWRU, having previously been an adjunct faculty
member in the Department of Orthopaedic Surgery for thirteen years.
"We are excited that Scott will be joining our executive leadership team and
further broadening our clinical and scientific expertise while also
strengthening our capabilities in the critical areas of evidence-based
medicine," stated Kevin A. Lobo, President and Chief Executive Officer.
Stryker is one of the world's leading medical technology companies and is
dedicated to helping healthcare professionals perform their jobs more
efficiently while enhancing patient care. The Company offers a diverse array of
innovative medical technologies, including reconstructive, medical and surgical,
and neurotechnology and spine products to help people lead more active and more
satisfying lives. For more information about Stryker, please visit
www.stryker.com.
Contacts
For investor inquiries please contact:
Katherine A. Owen, Stryker Corporation, 269-385-2600 or
katherine.owen@stryker.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Stryker Corporation via Thomson Reuters ONE
[HUG#1668772]
Press Release $SYK Stryker Corporation
Kalamazoo, Michigan - (January 7, 2013) - Stryker Corporation (NYSE:SYK) announced that Scott P. Bruder, MD, PhD has joined the Company in the newly created position of Vice President, Chief Medical and Scientific Officer, reporting to Kevin A. Lobo, President and Chief Executive Officer. In this role, Dr. Bruder will oversee the clinical and scientific efforts of Stryker Corporation, including academic, industrial and governmental scientific partnerships. In addition, he will represent Stryker as the leading medical authority of the Company for trade associations, regulatory bodies, and other entities while also partnering with our teams across the organization. Dr. Bruder has a long and distinguished track record of performance with more than 20 issued and pending patents, nearly 150 publications and numerous honors from the American Academy of Orthopaedic Surgeons, the Orthopaedic Research Society and the Association of Bone and Joint Surgeons. For the past five years, Dr. Bruder worked at Becton, Dickinson and Company as the Chief Science and Technology Officer, where he was responsible for identifying and cultivating new growth opportunities, improving the product development system and enhancing global research capabilities. Prior to that, Dr. Bruder spent 8 years at Johnson & Johnson in a series of senior executive and scientific roles in various businesses. Earlier in his career, Dr. Bruder held leadership roles at Anika Therapeutics and Osiris Therapeutics. Dr. Bruder is a graduate from Brown University and Case Western Reserve University (CWRU) School of Medicine, where he also earned a PhD in stem cell biology, before obtaining additional surgical training at the University of Pennsylvania. He maintains an active academic presence as an Adjunct Professor of Biomedical Engineering at CWRU, having previously been an adjunct faculty member in the Department of Orthopaedic Surgery for thirteen years. "We are excited that Scott will be joining our executive leadership team and further broadening our clinical and scientific expertise while also strengthening our capabilities in the critical areas of evidence-based medicine," stated Kevin A. Lobo, President and Chief Executive Officer. Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com. Contacts For investor inquiries please contact: Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Stryker Corporation via Thomson Reuters ONE [HUG#1668772]